Skip to main content
Research to Practice

Tumor Types

  • Breast cancers
  • Dermatologic cancers
  • Gastrointestinal cancers
  • Genitourinary cancers
  • Gynecologic cancers
  • Hematologic cancers
  • Lung cancer
  • Multitumor

More Ways To Browse

  • Latest Programs
  • Collections
  • Symposium Proceedings
  • Faculty Presentations
  • Nursing Programs
  • Micro Learning
  • Oncology Today w/ Dr. Neil Love
  • Podcasts
Search
  • Events
  • About us
  • Contact us
  • CME tests
  • Log in
  • Sign up

Past Events

  • Jun 2

    Exciting CME Events in Chicago You Do Not Want to Miss

    Consensus or Controversy? Documenting and Discussing Investigators’ Approaches to the Management of Myelofibrosis

    ExploreConsensus or Controversy? Documenting and Discussing Investigators’ Approaches to the Management of Myelofibrosis
  • Jun 1

    Exciting CME Events in Chicago You Do Not Want to Miss

    Second Opinion: Investigators Provide Perspectives on the Current and Future Use of Novel Therapies for Non-Hodgkin Lymphoma

    ExploreSecond Opinion: Investigators Provide Perspectives on the Current and Future Use of Novel Therapies for Non-Hodgkin Lymphoma
  • Jun 1

    Exciting CME Events in Chicago You Do Not Want to Miss

    Consensus or Controversy? Documenting and Discussing Investigators’ Approaches to the Management of Relapsed/Refractory Multiple Myeloma

    ExploreConsensus or Controversy? Documenting and Discussing Investigators’ Approaches to the Management of Relapsed/Refractory Multiple Myeloma
  • Jun 1

    Exciting CME Events in Chicago You Do Not Want to Miss

    What Clinicians Want to Know: Addressing Community Oncologists’ Questions About the Current and Future Role of Antibody-Drug Conjugates in the Management of Breast Cancer

    ExploreWhat Clinicians Want to Know: Addressing Community Oncologists’ Questions About the Current and Future Role of Antibody-Drug Conjugates in the Management of Breast Cancer
  • May 31

    Exciting CME Events in Chicago You Do Not Want to Miss

    What Clinicians Want to Know: Addressing Community Oncologists’ Questions About the Roles of CAR T-Cell Therapy and Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma

    ExploreWhat Clinicians Want to Know: Addressing Community Oncologists’ Questions About the Roles of CAR T-Cell Therapy and Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma
  • May 31

    Exciting CME Events in Chicago You Do Not Want to Miss

    What Clinicians Want to Know: Addressing Community Oncologists’ Questions About the Current and Future Management of Endometrial Cancer

    ExploreWhat Clinicians Want to Know: Addressing Community Oncologists’ Questions About the Current and Future Management of Endometrial Cancer
  • May 31

    Exciting CME Events in Chicago You Do Not Want to Miss

    Consensus or Controversy? Documenting and Discussing Investigators’ Approaches to the Use of Oral SERDs and Agents Targeting the PI3K/AKT/mTOR Pathway in Breast Cancer

    ExploreConsensus or Controversy? Documenting and Discussing Investigators’ Approaches to the Use of Oral SERDs and Agents Targeting the PI3K/AKT/mTOR Pathway in Breast Cancer
  • May 30

    Exciting CME Events in Chicago You Do Not Want to Miss

    Second Opinion: Investigators Provide Perspectives on the Current and Future Management of Small Cell Lung Cancer

    ExploreSecond Opinion: Investigators Provide Perspectives on the Current and Future Management of Small Cell Lung Cancer
  • May 30

    Exciting CME Events in Chicago You Do Not Want to Miss

    What Clinicians Want to Know: Addressing Community Oncologists’ Questions About the Care of Patients with Prostate Cancer

    ExploreWhat Clinicians Want to Know: Addressing Community Oncologists’ Questions About the Care of Patients with Prostate Cancer
  • May 30

    Exciting CME Events in Chicago You Do Not Want to Miss

    Consensus or Controversy? Documenting and Discussing Investigators’ Approaches to the Management of Ovarian Cancer

    ExploreConsensus or Controversy? Documenting and Discussing Investigators’ Approaches to the Management of Ovarian Cancer
  • May 29

    Exciting CME Events in Chicago You Do Not Want to Miss

    Consensus or Controversy? Documenting and Discussing Investigators’ Approaches to the Management of Advanced Gastroesophageal Cancers

    ExploreConsensus or Controversy? Documenting and Discussing Investigators’ Approaches to the Management of Advanced Gastroesophageal Cancers
  • May 29

    Exciting CME Events in Chicago You Do Not Want to Miss

    Consensus or Controversy? Documenting and Discussing Investigators’ Approaches to the Management of Colorectal Cancer

    ExploreConsensus or Controversy? Documenting and Discussing Investigators’ Approaches to the Management of Colorectal Cancer
  • May 29

    Exciting CME Events in Chicago You Do Not Want to Miss

    Cases from the Community: Investigators Discuss the Optimal Management of Chronic Lymphocytic Leukemia

    ExploreCases from the Community: Investigators Discuss the Optimal Management of Chronic Lymphocytic Leukemia
  • May 29

    Exciting CME Events in Chicago You Do Not Want to Miss

    Cases from the Community: Investigators Discuss the Optimal Management of EGFR-Mutated Non-Small Cell Lung Cancer

    ExploreCases from the Community: Investigators Discuss the Optimal Management of EGFR-Mutated Non-Small Cell Lung Cancer
  • May 17

    American Urological Association Annual Meeting

    Second Opinion: Investigators Provide Perspectives on the Current and Future Management of Prostate Cancer

    ExploreSecond Opinion: Investigators Provide Perspectives on the Current and Future Management of Prostate Cancer
  • May 17

    American Urological Association Annual Meeting

    Second Opinion: Optimal Management of Localized Renal Cell Carcinoma

    ExploreSecond Opinion: Optimal Management of Localized Renal Cell Carcinoma
  • May 16

    Annual ONS Congress

    Recent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Oral Selective Estrogen Receptor Degraders (SERDs) in Breast Cancer

    ExploreRecent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Oral Selective Estrogen Receptor Degraders (SERDs) in Breast Cancer
  • May 16

    Annual ONS Congress

    Recent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Optimizing the Use of CDK4/6 Inhibitors in the Management of HR-Positive Breast Cancer

    ExploreRecent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Optimizing the Use of CDK4/6 Inhibitors in the Management of HR-Positive Breast Cancer
  • May 16

    Annual ONS Congress

    Recent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Management of Relapsed/Refractory Multiple Myeloma

    ExploreRecent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Management of Relapsed/Refractory Multiple Myeloma
  • May 15

    Annual ONS Congress

    Recent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Bispecific Antibodies, Antibody-Drug Conjugates and BTK Inhibitors in NHL and CLL

    ExploreRecent Advances in Cancer Care — New Paradigms, Novel Agents and What It Means for the Oncology Nurse: Bispecific Antibodies, Antibody-Drug Conjugates and BTK Inhibitors in NHL and CLL
  • Page 1of 2
  • Page 2of 2
  • Next page
Research To Practice
  • About us
  • Contact us
  • Podcasts
  • Jobs

Copyright © 2026 Research To Practice, All rights reserved.

  • Privacy Policy
  • Terms of Use
  • Facebook
  • LinkedIn
  • X
  • Instagram
  • Tiktok
Opens in new window